Medifast (MED) Tops Q3 EPS by 4c
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $12.05 -0.74%
Revenue Growth %: -24.3%
Financial Fact:
Net income: 6.07M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: -24.3%
Financial Fact:
Net income: 6.07M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q3 EPS of $0.55, $0.04 better than the analyst estimate of $0.51. Revenue for the quarter came in at $77.2 million versus the consensus estimate of $74.94 million.
GUIDANCE:
Medifast sees Q4 2017 EPS of $0.46-$0.49. Medifast sees Q4 2017 revenue of $71.4-74.4 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- Zumiez, Inc. (ZUMZ) Misses Q2 EPS by 6c, Misses on Revenue; Offers Q3 Guidance
- Frequency Electronics (FEIM) Tops Q1 EPS by 12c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
